Form 4: Sean Carney Acquires 11,247 Shares of Beta Bionics Stock

Director Sean Carney acquired 11,247 shares of Beta Bionics, Inc. common stock on March 15, 2025, through a restricted stock unit award.

Summary

• On March 15, 2025, Sean Carney, a director of Beta Bionics, Inc., acquired 11,247 shares of common stock.
• The acquisition was a result of a restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.
• The shares were acquired at a price of $0.
• Following the transaction, Carney directly owns 11,247 shares of Beta Bionics common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. The acquisition of shares by a director could be interpreted as slightly positive, but without further context, it's difficult to assign a strong sentiment.

Positives

• The acquisition of shares by a director could be seen as a positive sign, indicating confidence in the company's future.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholders if it signals confidence from a company director.

Key Dates